The Effects of Health Behavior Changing Program for Systolic Blood Pressure Reduction Among Thai Buddhist Monks, Thailand.

Thai Buddhist monks' lifestyle has made them likely to get non-communicable diseases. Therefore, the Ministry of Public Health of Thailand has conducted a health behavior-changing program for non-communicable diseases prevention among Thai Buddhist monks. This study aims to examine the effectiveness of the health behavior-changing Program for Non- communicable diseases prevention among 4,786 Thai Buddhist monks who were risk group. They were on the program for 6 months. from January 1st, 2021 to June 30th, 2021. Descriptive statistics were used to describe the characteristics of the subjects and Paired t-test was used to compare the mean difference. The results showed that the health behavior-changing program can reduce Fasting Blood Sugar, Body Mass Index, Risk score, Hypertension, and Smoking scores. Therefore, this program should be used for reducing risk factors of non-communicable diseases among Thai monks in the Upper Northeast region of Thailand.

The Clinical and Biochemical Parameter Data: Effect of High Blood Glucose on Diabetic Nephropathy Among Non-Insulin-Dependent Diabetes Mellitus (NIDDM), Thailand.

BACKGROUND: Diabetic nephropathy (DN) is one of the long-term complications of patients with type 2 diabetes. The leading causes of DN are high blood glucose and hyper systolic blood pressure. METHODS: A retrospective cohort study was performed to explore the effects of high blood sugar and hyper systolic blood pressure on DN among 660 non-insulin-dependent diabetes mellitus. Data was collected from the HosXP program and medical records from 2016 to 2020. The Forest plot was used to examine the effect of hypertriglyceridemia and hyper systolic blood pressure with DN. RESULTS: The results confirmed that the factors associated with DN were male, age ≥ 60years, diabetic duration ≥ 10 years, systolic BP ≥ 130 mmHg, and HbA1c ≥ 6%. CONCLUSION: The health promotion program should be comprised of the control of blood glucose and systolic blood pressure procedure especially male patients with age ≥ 60 years and diabetic duration ≥ 10 years.

The Information from Medical Data Based: Prevalence and Expected Median Survival Time of Drug-Induced Hepatotoxicity Among Thai Patients with TB.

BACKGROUND: Hepatotoxicity is very frequent and is a dangerously adverse effect of anti-TB medications. This effect can reduce the effectiveness of the treatment by compromising treatment regimens. Among these first-line quadruple therapy drugs (INH, RMP, PZA, and EMB), INH, RMP, and PZA are metabolized mostly by the liver, and due to this, are likely hepatotoxic. However, the survival times of hepatotoxicity among patients with TB in Thailand are currently not available. The aims of the present study were to assess the prevalence and survival time of drug-induced hepatotoxicity in patients with TB. METHODS: A cross-sectional retrospective study was performed to explore the survival time of the development of drug-induced hepatotoxicity among 327 patients with TB who received standard drug treatment at the TB clinic in Phichit Hospital. Data was collected from the HOSxP program and medical records from 2016 to 2018. Kaplan-Meier and Cox's regressions were used for data analysis. RESULTS: The results showed that prevalence of drug-induced hepatotoxicity was 6.42% and confirmed that patients with TB who were <50 years of age will be a median survival time on drug-induced hepatotoxicity is 17 days and 30 days for those who age group ≥50 years. CONCLUSION: The median survival time of drug-induced hepatotoxicity among patients with TB who were <50 years of age is 17 days. So, patients with TB whose ages are less than 50 years should receive liver function tests such as AST and ALT and investigate risk behavior before receiving the anti- TB treatment.